S
Steven Joseph Haas
Researcher at Monash University
Publications - 28
Citations - 2451
Steven Joseph Haas is an academic researcher from Monash University. The author has contributed to research in topics: Randomized controlled trial & Heart failure. The author has an hindex of 17, co-authored 28 publications receiving 2357 citations. Previous affiliations of Steven Joseph Haas include Alfred Hospital.
Papers
More filters
Journal ArticleDOI
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
TL;DR: To target higher haemoglobin concentrations when treating patients with anaemia caused by chronic kidney disease with recombinant human erythropoietin puts such patients at increased risk of death, according to current guidelines.
Journal ArticleDOI
Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.
TL;DR: There was a nonsignificantly higher incidence of developing hypertension compared with nonselective NSAIDs, as was observed with rofecoxib compared with celecoxib, and cyclooxygenase-2 inhibitors were associated with a point-estimate BP elevation compared with placebo and nonselectIVE NSAIDs.
Journal ArticleDOI
Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials
Franklin L. Rosenfeldt,Steven Joseph Haas,Henry Krum,Afif Hadj,Afif Hadj,K Ng,Jee Yoong Leong,Jee Yoong Leong,Gerald F. Watts +8 more
TL;DR: It is concluded that coenzyme Q10 has the potential in hypertensive patients to lower systolic blood pressure by up to 17 mm Hg and diastolicBlood pressure by 10 mm Hg without significant side effects.
Journal ArticleDOI
Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.
Steven Joseph Haas,Steven Joseph Haas,Richard Hill,Henry Krum,Danny Liew,Andrew Tonkin,Lisa L Demos,Karen Stephan,John J McNeil +8 more
TL;DR: Clozapine is uncommonly but importantly related to myocarditis, often fatal or near fatal and sometimes in relatively young patients with early onset after treatment initiation, and a case-control study would be suitable for investigation of baseline predictors.
Journal ArticleDOI
Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials
TL;DR: A meta-analysis of beta-blocker trials that reported mortality outcomes in patients with diabetes mellitus who had CHF to pool all available trial evidence on the benefits (or otherwise) of these agents in this setting appears to derive prognostic benefit from beta-blocking therapy.